The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibitionIrantzu Anzar, Trevor Clancy, Leonardo A. Meza‐Zepeda et al.|Frontiers in Immunology|2023Cited by 12
ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.Candace L. Haddox, Suzanne George, Jonathan A. Fletcher et al.|Journal of Clinical Oncology|2025Cited by 1
The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibitionIrantzu Anzar, Trevor Clancy, Brandon Malone et al.|medRxiv|2023Cited by 0